Login

Insider Transactions

What Soliton, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Bisson Lori Chief Financial Officer Dec 16 Disposition to Issuer · D −60,000 $22.60 −$1.36M 0
Klemp Walter V Executive Chairman Dec 16 Disposition to Issuer · D −425,000 $22.60 −$9.61M 0
Capelli Christopher CSO and Vice Chairman Dec 16 Disposition to Issuer · D −175,000 $22.60 −$3.96M 0
Capelli Christopher CSO and Vice Chairman Dec 16 Disposition to Issuer · D −263,440 $22.60 −$5.95M 0
Remeditex Ventures Llc 10% owner Dec 16 Disposition to Issuer · D −9,214,277 $22.60 −$208M 0
Tanner Joe D Chief Operating Officer Dec 16 Disposition to Issuer · D −80,000 $22.60 −$1.81M 0
Remeditex Ventures Llc 10% owner Jun 30 Open-market buy · P +120,481 $8.30 +$1M 9,214,277
Remeditex Ventures Llc 10% owner Oct 11 Open-market buy · P +155,280 — — 9,093,796
Remeditex Ventures Llc 10% owner Jun 19 Open-market buy · P +357,143 — — 8,938,516

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support